Optimization of Remotely Delivered Physical Activity Intervention for Breast Cancer Survivors

February 13, 2023 updated by: Siobhan M Phillips, Northwestern University

Designing With Dissemination in Mind: Optimization of a mHealth Physical Activity Intervention for Breast Cancer Survivors

The overall objective of the proposed research is to pilot test the feasibility and acceptability of a set of more scalable technology-supported physical activity promotion intervention strategies in breast cancer survivors using tMultiphase Optimization Strategy Trial (MOST) methodology. MOST involves highly efficient randomized experimentation to assess the effects of individual intervention strategies, and thereby identify which strategies and what strategy levels make the important contributions to the overall program's effect on physical activity. This information then guides assembly of an optimized physical activity program, that achieves target outcomes with least resource consumption and participant burden. The resulting intervention will have great potential for scalability because it uses technology (smartphones) participants already own and requires no on-site visits.

Study Overview

Study Type

Interventional

Enrollment (Actual)

280

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60611
        • Northwestern University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Diagnosed with Stage I-III breast cancer within the last 5 years
  2. Have completed last cancer treatment (adjuvant chemotherapy, radiation therapy or surgery) at least 3 months prior to enrollment
  3. English speaking
  4. Currently participate in less than 60 minutes of moderate and vigorous physical activity per week
  5. Own a smartphone
  6. Have access to a computer with Internet
  7. Participants may be using adjuvant endocrine therapies.
  8. Willing to be waitlisted for future wave if current wave reaches capacity

Exclusion Criteria:

-Women will be excluded if they report any of the following:

  1. Respiratory, joint or cardiovascular problems precluding physical activity
  2. Metastatic disease
  3. Planned elective surgery during duration of the intervention/follow-up that would interfere with participation (e.g., breast reconstructive surgery).

ONLY IF PARTICIPATING IN OPTIONAL BLOOD COLLECTION:

  1. A prior cardiovascular event (i.e. stroke, myocardial infarction)
  2. Have been diagnosed with an acute or chronic immune system medical conditions, or conditions that impact immune and endocrine function (e.g., CFS, Lupus, rheumatoid arthritis, Hepatitis C, or immunosuppressive treatment requiring conditions)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Condition #1
core, support calls
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Experimental: Experimental Condition #2
core, support calls, app+
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive "deluxe" version of smartphone app with additional features.
Experimental: Experimental Condition #3
core, support calls, buddy
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Experimental: Experimental Condition #4
core, support calls, online gym
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive access to online exercise videos.
Experimental: Experimental Condition #5
core, support calls, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive motivational app notifications
Experimental: Experimental Condition #6
core, app+
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive "deluxe" version of smartphone app with additional features.
Experimental: Experimental Condition #7
core, app+, buddy
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Experimental: Experimental Condition #8
core, app+, online gym
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will receive access to online exercise videos.
Experimental: Experimental Condition #9
core, app+, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will receive motivational app notifications
Experimental: Experimental Condition #10
core, buddy
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Experimental: Experimental Condition #11
core, buddy, online gym
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive access to online exercise videos.
Experimental: Experimental Condition #12
core, buddy, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive motivational app notifications
Experimental: Experimental Condition #13
core, online gym
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive access to online exercise videos.
Experimental: Experimental Condition #14
core, online gym, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive access to online exercise videos.
Participants will receive motivational app notifications
Experimental: Experimental Condition #15
core, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive motivational app notifications
Experimental: Experimental Condition #16
core, support calls, app+, buddy
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Experimental: Experimental Condition #17
core, support calls, app+, online gym
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will receive access to online exercise videos.
Experimental: Experimental Condition #18
core, support calls, app+, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will receive motivational app notifications
Experimental: Experimental Condition #19
core, support calls, buddy, online gym
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive access to online exercise videos.
Experimental: Experimental Condition #20
core, support calls, buddy, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive motivational app notifications
Experimental: Experimental Condition #21
core, support calls, online gym, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive access to online exercise videos.
Participants will receive motivational app notifications
Experimental: Experimental Condition #22
core, app+, buddy, online gym
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive access to online exercise videos.
Experimental: Experimental Condition #23
core, app+, buddy, online gym, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive access to online exercise videos.
Participants will receive motivational app notifications
Experimental: Experimental Condition #24
core, support calls, buddy, online gym, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive access to online exercise videos.
Participants will receive motivational app notifications
Experimental: Experimental Condition #25
core, buddy, online gym, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive access to online exercise videos.
Participants will receive motivational app notifications
Experimental: Experimental Condition #26
core, app+, online gym, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will receive access to online exercise videos.
Participants will receive motivational app notifications
Experimental: Experimental Condition #27
core, support calls, app+, buddy, online gym
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive access to online exercise videos.
Experimental: Experimental Condition #28
core, support calls, app+, buddy, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive motivational app notifications
Experimental: Experimental Condition #29
core, support calls, app+, online gym, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will receive access to online exercise videos.
Participants will receive motivational app notifications
Experimental: Experimental Condition #30
core
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Experimental: Experimental Condition #31
core, app+, buddy, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive motivational app notifications
Experimental: Experimental Condition #32
core, support calls, app+, buddy, online gym, app notifications
The core intervention will include educational materials, access to a basic smartphone app and a Fitbit.
Participants will receive 6 bi-weekly phone calls from study staff.
Participants will receive "deluxe" version of smartphone app with additional features.
Participants will choose a buddy to receive a Fitbit and support them during the intervention.
Participants will receive access to online exercise videos.
Participants will receive motivational app notifications

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to a 12 Week Technology Supported Physical Activity Intervention
Time Frame: 12 weeks
Adherence during the 12 week intervention will be monitored continuously using study app. This measures the average percentage of days each participant randomized wore the Fitbit during weeks 1 to 12.
12 weeks
Participant Retention
Time Frame: 12 weeks
Percentage of participants retained at the end of the 12 week intervention of those randomized [(# of participants randomized who completed at least 1 outcome assessment measure at 12 weeks)/ # randomized*100].
12 weeks
Intervention Reach
Time Frame: Baseline
Percentage of individuals randomized of those who were sent a study screening survey
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Moderate to Vigorous Physical Activity From Before to After a 12-Week Intervention
Time Frame: Change from baseline to 12 weeks
Physical activity will be measured at baseline and at 12 weeks. The ActiGraph accelerometer will be used. At each time point, participants will wear the device for 7 consecutive days during all waking hours, except when bathing or swimming. Each valid minute of wear time will be classified according to intensity (counts/min) using commonly accepted cut-points: sedentary (<100), light activity (100-2019) and moderate/vigorous physical activity (≥2020).
Change from baseline to 12 weeks
Change in Moderate to Vigorous Physical Activity From Pre-Intervention to 24-week Follow-up
Time Frame: Change from baseline to 24 weeks
Physical activity will be measured at baseline and at 24 weeks. The ActiGraph accelerometer will be used. At each time point, participants will wear the device for 7 consecutive days during all waking hours, except when bathing or swimming. Each valid minute of wear time will be classified according to intensity (counts/min) using commonly accepted cut-points: sedentary (<100), light activity (100-2019) and moderate/vigorous physical activity (≥2020).
Change from baseline to 24 weeks
Change in Fatigue From Before to After a 12-Week Intervention
Time Frame: Change from baseline to 12 weeks
Fatigue is measured at baseline and 12 weeks using the Patient Reported Outcomes Measurement Information System (PROMIS)-Fatigue 8a health measure. T-scores range from 33.1 to 77.8 Higher scores indicate more fatigue. T-score metric with a mean of 50 and standard deviation of 10 in the U.S. general population.
Change from baseline to 12 weeks
Change in Fatigue From Pre-Intervention to 24-Week Follow-up
Time Frame: Change from baseline to 24 weeks
Fatigue will be measured at baseline and 24 weeks using the Patient Reported Outcomes Measurement Information System (PROMIS)-Fatigue 8a health measure. T-scores range from 33.1 to 77.8 Higher scores indicate more fatigue. T-score metric with a mean of 50 and standard deviation of 10 in the U.S. general population.
Change from baseline to 24 weeks
Change in Physical Function From Before to After a 12-Week Intervention
Time Frame: Change from baseline to 12 weeks
Physical function will be measured at baseline and 12 weeks using the Patient Reported Outcomes Measurement Information System (PROMIS)-physical function 20a health measure. T-scores range from 32.7 to 62.7. Higher scores indicate better physical functioning. T-score metric with a mean of 50 and standard deviation of 10 in the U.S. general population.
Change from baseline to 12 weeks
Treatment Effects for Physical Function From Pre-Intervention to 24-week Follow-up
Time Frame: Change from baseline to 24 weeks
Physical function will be measured at baseline and 24 weeks using the Patient Reported Outcomes Measurement Information System (PROMIS)-physical function 20a health measure. T-scores range from 32.7 to 62.7. Higher scores indicate better physical functioning. T-score metric with a mean of 50 and standard deviation of 10 in the U.S. general population. The treatment effect is calculated as the mean difference in the change in physical function between baseline and 24-weeks for each component on versus off.
Change from baseline to 24 weeks
Change in Depression From Before to After a 12-Week Intervention
Time Frame: Change from baseline to 12 weeks
Depression will be measured at baseline and 12 weeks using the Patient Reported Outcomes Measurement Information System (PROMIS)-Depression 8a health measure. T-scores range from 38.2 to 81.3. Higher scores indicate more depression. T-score metric with a mean of 50 and standard deviation of 10 in the U.S. general population.
Change from baseline to 12 weeks
Change in Depression From Pre-Intervention to 24-week Follow-up
Time Frame: Change from baseline to 24 weeks
Depression will be measured at baseline and 24 weeks using the Patient Reported Outcomes Measurement Information System (PROMIS)-Depression 8a health measure. T-scores range from 38.2 to 81.3. Higher scores indicate more depression. T-score metric with a mean of 50 and standard deviation of 10 in the U.S. general population.
Change from baseline to 24 weeks
Adherence to During the Full 24-Week Study Period
Time Frame: 24 weeks
Adherence during the 24-week study period will be monitored continuously using study app. This measure the average percentage of days each randomized participant wore the Fitbit from weeks 1 to 24.
24 weeks
Participant Retention at 24 Week Follow-up
Time Frame: 24 weeks
Percentage of participants retained at 24 weeks of those randomized
24 weeks
Change in Interleukin-6 (IL-6) From Before to After a12 Week Intervention (Optional)
Time Frame: Change from baseline to 12 weeks
Interleukin-6 (IL-6) will be self-collected via finger prick to obtain dried blood spot and will be quantified using a standard multiplex electrochemiluminescent immunoassay protocol.
Change from baseline to 12 weeks
Change in Interleukin-6 (IL-6) From Pre-Intervention to 24-week Follow-up (Optional)
Time Frame: Change from baseline to 24 weeks
Interleukin-6 (IL-6) will be self-collected via finger prick to obtain dried blood spot and will be quantified using a standard multiplex electrochemiluminscent immunoassay protocol.
Change from baseline to 24 weeks
Change in Interleukin-10 (IL-10) From Before to After a 12 Week Intervention (Optional)
Time Frame: Change from baseline to 12 weeks
Interleukin-10 (IL-10) will be self-collected via finger prick to obtain dried blood spot and will be quantified using a standard multiplex electrochemiluminscent immunoassay protocol.
Change from baseline to 12 weeks
Change in Interleukin-10 (IL-10) From Pre-Intervention to 24-week Follow-up (Optional)
Time Frame: Change from baseline to 24 weeks
Interleukin-10 (IL-10) will be self-collected via finger prick to obtain dried blood spot and will be quantified using a standard multiplex electrochemiluminscent immunoassay protocol. Higher IL-10 may have protective effects.
Change from baseline to 24 weeks
Change in Tumor Necrosis Factor-alpha (TNFα) From Before to After a12 Week Intervention (Optional)
Time Frame: Change from baseline to 12 weeks
tumor necrosis factor-alpha (TNFα) will be self-collected via finger prick to obtain dried blood spot and will be quantified using a standard multiplex electrochemiluminscent immunoassay protocol. Lower values are better.
Change from baseline to 12 weeks
Change in Tumor Necrosis Factor-alpha (TNFα) From Pre-Intervention to 24-week Follow-up (Optional)
Time Frame: Change from baseline to 24 weeks
tumor necrosis factor-alpha (TNFα) will be self-collected via finger prick to obtain dried blood spot and will be quantified using a standard multiplex electrochemiluminscent immunoassay protocol. TLower values are better.
Change from baseline to 24 weeks
Change in C-reactive Protein (CRP) From Before to After a12 Week Intervention (Optional)
Time Frame: Change from baseline to 12 weeks
C-reactive protein (CRP) will be self-collected via finger prick to obtain dried blood spot and will be quantified using ELISA. Lower values are better.
Change from baseline to 12 weeks
Change in C-reactive Protein (CRP) From Pre-Intervention to 24-week Follow-up (Optional)
Time Frame: Change from baseline to 24 weeks
C-reactive protein (CRP) will be self-collected via finger prick to obtain dried blood spot and will be quantified using standard ELISA. Lower values are better.
Change from baseline to 24 weeks
Change in Triglycerides From Before to After a 12 Week Intervention (Optional)
Time Frame: Change from baseline to 12 weeks
Triglycerides are self-collected via finger prick to obtain a dried blood spot and quantified using a standard coupled enzymatic protocol.
Change from baseline to 12 weeks
Change in Triglycerides From Pre-Intervention to 24-week Follow-up (Optional)
Time Frame: Change from baseline to 24 weeks
Triglycerides are self-collected via finger prick to obtain a dried blood spot and quantified using a standard coupled enzymatic protocol. Lower values are better.
Change from baseline to 24 weeks
Change in Blood Glucose From Before to After a 12 Week Intervention (Optional)
Time Frame: Change from baseline to 12 weeks
Blood glucose is self-collected via finger prick to obtain a dried blood spot and quantified using a standard coupled enzymatic protocol.
Change from baseline to 12 weeks
Change in Blood Glucose From Pre-Intervention to 24-week Follow-up (Optional)
Time Frame: Change from baseline to 24 weeks
Blood Glucose is self-collected via finger prick to obtain a dried blood spot and quantified using a standard coupled enzymatic protocol.
Change from baseline to 24 weeks
Change in High Density Lipoprotein Cholesterol (HDL) From Before to After a12 Week Intervention (Optional)
Time Frame: Change from baseline to 12 weeks
High density lipoprotein cholesterol (HDL) is self-collected via finger prick to obtain a dried blood spot and quantified using a standard coupled enzymatic protocol.
Change from baseline to 12 weeks
Change in High Density Lipoprotein Cholesterol (HDL) From Pre-Intervention to 24-week Follow-up(Optional)
Time Frame: Change from baseline to 24 weeks
High density lipoprotein cholesterol (HDL) is self-collected via finger prick to obtain a dried blood spot and quantified using a standard coupled enzymatic protocol.
Change from baseline to 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 24, 2017

Primary Completion (Actual)

June 17, 2019

Study Completion (Actual)

June 17, 2019

Study Registration Dates

First Submitted

April 18, 2017

First Submitted That Met QC Criteria

April 24, 2017

First Posted (Actual)

April 27, 2017

Study Record Updates

Last Update Posted (Estimate)

March 10, 2023

Last Update Submitted That Met QC Criteria

February 13, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • K07CA196840 (U.S. NIH Grant/Contract)
  • R21CA219028-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data collected in this study will be made available to other researchers in compliance with the NIH Data Sharing Policy.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Activity

Clinical Trials on Core

Subscribe